ABSTRACT NUMBER: ESOC2026A1682 SAFETY AND EFFICACY OF BRIDGING THERAPY VERSUS INTRAVENOUS THROMBOLYSIS ALONE OR DIRECT ENDOVASCULAR THROMBECTOMY BEYOND 4.5 HOURS: A POST-HOC ANALYSIS OF THE CHABLIS-T TRIALS
Xinru Wang, Ying Guo, Zhijiao He, Siyuan Li, Anqi Zhang, Lan Hong, Xin Cheng, Qiang Dong · 2026
Read ABSTRACT NUMBER: ESOC2026A1682 SAFETY AND EFFICACY OF BRIDGING THERAPY VERSUS INTRAVENOUS THROMBOLYSIS ALONE OR DIRECT ENDOVASCULAR THROMBECTOMY BEYOND 4.5 HOURS: A POST-HOC ANALYSIS OF THE CHABLIS-T TRIALS by Xinru Wang, Ying Guo, Zhijiao He, Siyuan Li, Anqi Zhang, Lan Hong, Xin Cheng, Qiang Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146098.txt.
Description
Xinru Wang and seven co-authors reanalyzed in 2026 two Chinese stroke trials to ask whether combining treatments beats either alone in late arrivals. Patients reaching care between four and a half and twenty-four hours after a major stroke sit outside the classic drug window. Three strategies competed: clot drug plus catheter removal, drug alone, or catheter alone.
The main safety measure was bleeding inside the skull within two days, with recovery scores beside it. Late-window care is expanding fast, and knowing whether the drug adds benefit or only bleeding risk steers ambulances and budgets alike.
Catalog record
| CREATOR | Xinru Wang, Ying Guo, Zhijiao He, Siyuan Li, Anqi Zhang, Lan Hong, Xin Cheng, Qiang Dong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |